| The Global Point of Care Diagnostics Market in terms of revenue is expected to be worth $75.5 billion by 2027, growing at a CAGR of 10.7% in the upcoming years.
The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. In the latest edition of the report, new product and sample segments have been added. The updated report will have a segment dedicated to providing a detailed understanding of different types of point of care products and samples. The growth of this market can be attributed to the high prevalence of respiratory diseases such as influenza, cardiac diseases, and infectious diseases (where point of care tests can greatly improve the management of these diseases, especially in developing countries where access to timely medical care is a challenge and the healthcare infrastructure is antiquated and sparse). Furthermore, with the increasing availability of point of care testing products via online platforms, supportive government policies, and an increase in the number of CLIA-waived point of care tests, healthcare decentralisation and greater investments and funding for product development are expected to accelerate the growth of the market in the coming years. |
